NCT03855800 Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
| NCT ID | NCT03855800 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Pancreas Cyst |
| Study Type | INTERVENTIONAL |
| Enrollment | 800 participants |
| Start Date | 2018-05-11 |
| Primary Completion | 2030-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 800 participants in total. It began in 2018-05-11 with a primary completion date of 2030-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.
Eligibility Criteria
Inclusion Criteria: * Patients with pancreatic cystic lesions meeting Fukuoka worrisome or Fukuoka high-risk criteris * Patients with suspected cystic neoplasm of the pancreas * Able to provide written informed consent Exclusion Criteria: * Pregnant and/or nursing * Incarceration * Imaging showing possible pancreatic cancer * Prior history of pancreatic cancer or pancreatic surgery * History of receiving systemic chemotherapy or abdominal radiation within the last 5 years * Previous therapy for a pancreatic cystic lesion * History of pancreatic necrosis * Diagnosis of cancer (other than non-melanoma skin cancer) within the last 5 years
Contact & Investigator
Shounak Majumder, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT03855800 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Pancreas Cyst. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03855800 currently recruiting?
Yes, NCT03855800 is actively recruiting participants. Contact the research team at rstincyststudy@mayo.edu for enrollment information.
Where is the NCT03855800 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT03855800 clinical trial?
NCT03855800 is sponsored by Mayo Clinic. The principal investigator is Shounak Majumder, MD at Mayo Clinic. The trial plans to enroll 800 participants.